OASIS: A New AI-Powered Tool for Measuring Meibomian Gland Health
Imagine cutting meibomian gland analysis from 20 minutes to just 3. That’s the power of OASIS. If you’ve ever treated…
When a Glaucoma Diagnosis Hits Home: Beyond Pressure Points and into Patient Lives
Newly diagnosed glaucoma patients carry more than IOP worries. From mental health dips to money matters, quality of care stretches…
latest posts
